ORAGENICS, INC. Litigation Settlement Gain
ORAGENICS, INC. (OGEN) had Litigation Settlement Gain of $700.00 thousand as of 2025-10-31, per its 10-Q filed 2025-11-07.
Financial Statements › Notes
us-gaap:LitigationSettlementGain · last filed 2025-11-07
- 2025-10-31: Litigation Settlement Gain $700.00K.
- 2025-09-30: Litigation Settlement Gain $700.00K.
| Period end | Litigation Settlement Gain |
|---|---|
| 2025-10-31 | $700.00K 10-Q · filed 2025-11-07 |
| 2025-09-30 | $700.00K 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |